Anti‐Müllerian hormone reflects the severity of polycystic ovary syndrome
Explore this paper's citation graph
Summary
To examine the relationship between anti‐Müllerian hormone (AMH) and the severity of the phenotype of patients with polycystic ovary syndrome (PCOS) and whether AMH can act as a diagnostic marker for PCOS, a large number of patients are diagnosed with PCOS.
- Type
- article
- Published
- 2017-03-01
- Cited by
- 34
- References
- 38
- Access
- Open access
- OpenAlex
- https://openalex.org/W2546812466
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:613144
Keywords
Polycystic ovary, Hyperandrogenism, Anti-Müllerian hormone, Medicine, Internal medicine
References
- Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.
- Age-related normogram for antral follicle count in women with polycystic ovary syndrome.
- Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries.
- Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
- Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
- The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
- Follicle number, and not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome
- Reference range for the antimüllerian hormone Generation II assay: a population study of 10,984 women, with comparison to the established Diagnostics Systems Laboratory nomogram.
- Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.
- Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
- Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data.
- Sustained fertility from 22 to 41 years of age in women with polycystic ovarian syndrome.
- Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.
- Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
- A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed?
- Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients.
- Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries
- Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
- Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries.
- Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism.
Cited by
- Elevated anti‐Mullerian hormone in lean women may not indicate polycystic ovarian syndrome
- Simplified 4‐item criteria for polycystic ovary syndrome: A bridge too far?
- Anti‐Müllerian Hormone in Girls with Premature Adrenarche: The Impact of Polycystic Ovary Syndrome History in their Mothers
- Circulating antimüllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term.
- Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes
- Polycystic ovary syndrome in adolescents.
- Is a woman’s chronological age or ‘ovarian age’ more important in determining perinatal outcome after assisted reproductive treatment?
- A study comparing the clinical and hormonal profile of late onset and persistent acne in adult females
- Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome
- A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome
- Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
- A prospective study of anti‐mullerian hormone and other ovarian and adrenal hormones in adult female acne
- Role of anti-Müllerian hormone and testosterone in follicular growth: a cross-sectional study
- Anti-Müllerian hormone as a driving force of polycystic ovary syndrome, independently from insulin resistance.
- The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
- Anti-Müllerian hormone: clinical implications in Gynecological Endocrinology. An update review
- PCOS Features and Steroid Profiles Among Young Adult Women with a History of Premature Adrenarche
- Myoinositol versus metformin pretreatment in GnRH-antagonist cycle for women with PCOS undergoing IVF: a double-blinded randomized controlled study
- Updated meta‐analysis on the diagnostic accuracy of serum anti‐Mullerian hormone in poly cystic ovary syndrome involving 13 509 subjects
- The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
Related papers
- Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome.
- Chinese and Western Medicine Treatment Progress of Obese-polycystic Ovary Syndrome
- Caring for women with polycystic ovary syndrome.
- Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.
- Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review
- Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS
- Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients
- The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
- Mullerian inhibiting substance (MIS) reflects ovarian and biochemical aberrations in polycystic ovary syndrome (PCOS) better than Inhibin B